It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...

Over the last four quarters, the company has surpassed consensus EPS estimates three times. Glaxo, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $10.42 ...

The history of the pharmaceutical industry in the town goes back to the post-war era, when Glaxo built a production site on a former iron works. At the time, pharmaceutical production sites were ...

BRENTFORD, Britain (AP) — BRENTFORD, Britain (AP) — GSK plc (GSK) on Wednesday reported fourth-quarter earnings of $530.5 million. On a per-share basis, the Brentford, Britain-based company ...

I've already discussed Astra's results this week. Here's why Glaxo looks by far the better bet. If you didn't bother delving into the results, you might wonder what the grounds for optimism are.

A Chinese court on Friday fined British drug-maker GlaxoSmithKline 3.0 billion Yuan (490 million dollars) following a nearly year-long bribery probe, the company said. The fine, levied by the ...

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

GSK (GSK) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.72 per share a year ago. These figures are ...

Will the recent positive trend continue leading up to its next earnings release, or is Glaxo due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take ...